Eton Pharmaceuticals Inc (ETON) financials · rev $80.0M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Eton Pharmaceuticals Inc (ETON) rev $80.0M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $80.0M | $39.0M |
| Cost of Revenue | $37.2M | $15.6M |
| Gross Profit | $42.7M | $23.4M |
| Operating Income | -$844.0K | -$2.60M |
| Net Income | -$4.60M | -$3.82M |
| EPS (Diluted) | -$0.17 | -$0.15 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $92.1M | $76.1M |
| Current Assets | $60.6M | $41.0M |
| Cash & Equivalents | $25.9M | $14.9M |
| Inventory | $15.4M | $15.2M |
| PP&E | $326.0K | $34.0K |
| Total Liabilities | $66.0M | $51.7M |
| Current Liabilities | $38.5M | $19.9M |
| Short-term Debt | $8.79M | N/A |
| Long-term Debt | $21.8M | $29.8M |
| Total Debt | $30.6M† | $29.8M† |
| Shareholders' Equity | $26.2M | $24.4M |
| Retained Earnings | -$112.5M | -$107.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $10.5M | $969.0K |
| CapEx | $333.0K | $26.0K |
| Investing Cash Flow | -$333.0K | -$40.0M |
| Financing Cash Flow | $815.0K | $32.6M |
| Net Change in Cash | $11.0M | -$6.45M |
| Free Cash Flow | $10.2M | $943.0K |
FAQ
What is ETON P/E and revenue?
Eton Pharmaceuticals Inc (ETON) rev $80.0M.
What is ETON revenue?
Eton Pharmaceuticals Inc last cached revenue is $80.0M (FY2025).
Is ETON profitable?
Eton Pharmaceuticals Inc last cached net income is -$4.60M (FY2025).
What are ETON total assets?
Eton Pharmaceuticals Inc last cached total assets are $92.1M (FY2025).
What is ETON free cash flow?
Eton Pharmaceuticals Inc last cached free cash flow is $10.2M (FY2025).
Not investment advice. Cached statements, not a live tape.